C.v. Herst

Biochemical Evidence for a Novel Low Molecular Weight 2-5A-Dependent RNase L in Chronic Fatigue Syndrome

Robert J. Suhadolnik, Daniel L. Peterson, Terence J. O’Brien et al. · Journal of Interferon & Cytokine Research · 1997 · 116 citations

Establishment and characterization of a neuroendocrine skin carcinoma cell line.

S. T. Rosen, Victor E. Gould, Helen R. Salwen et al. · PubMed · 1987 · 99 citations

Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.

Susan L. Cohn, Helen R. Salwen, Michael W. Quasney et al. · PubMed · 1990 · 88 citations

An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design

C.v. Herst, Scott Burkholz, John Sidney et al. · Vaccine · 2020 · 63 citations · Full text

Characterization of a novel myeloma cell line, MM.1.

Robin Goldman-Leikin, Helen R. Salwen, C.v. Herst et al. · PubMed · 1989 · 53 citations